Overview
A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
Status:
Completed
Completed
Trial end date:
2005-11-01
2005-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study is designed to evaluate the safety and effectiveness of an investigational drug, TRN-002 (crofelemer) to relieve the symptoms of diarrhea-predominant irritable bowel syndrome (IBS).Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.
Criteria
Inclusion Criteria:- Diagnosis of diarrhea predominant Irritable Bowel Syndrome
- Willingness to make daily calls on a touch-tone telephone
- Willingness to have an endoscopic and/or radiologic bowel evaluation, if you have not
received one since your IBS diagnosis and in the past 5 years
- Willingness to use an approved method of birth control
Exclusion Criteria:
- Serious medical or surgical conditions
- Gastrointestinal Cancers, Crohns Disease or Ulcerative Colitis
- Pregnancy or breast feeding